SCOPE 2020 attracts record attendance with more than 2,200 participants
A Leader in the Clinical Trial Industry: SCOPE Grows by more than 10% for the fifth consecutive year
The impressive executive audience at SCOPE came together for invaluable networking opportunities with more than 53% of the attendees titled as a decision-maker from leading Pharma (18%), Biotech companies (19%) and, CRO (36%). Industry leaders
and key decision-makers representing 28 different countries and more than 770 unique organizations shared case studies, collaborated on best practices, and provided unique perspectives on poignant issues that the field currently faces.